Old Web
English
Sign In
Acemap
>
authorDetail
>
Aleš Tvaroh
Aleš Tvaroh
Merck & Co.
Medicine
Interferon beta-1a
Observational study
Multiple sclerosis
Autoimmune disease
7
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis
2020
Frontiers in Neurology
Martina Novotná
Aleš Tvaroh
Jan Mareš
Show All
Source
Cite
Save
Citations (0)
Effect of subcutaneously administred interferon beta-1a on sibease activity in batients with slinically isolated syndrome – ATRACT observational study
2019
Ceska A Slovenska Neurologie A Neurochirurgie
Eva Meluzínová
Aleš Tvaroh
Monika Bludovská
Jiří Piťha
Martin Vališ
Jan Mares
Yvonne Benešová
Alena Martínková
Michal Dufek
Pavel Hradílek
R. Ampapa
Markéta Grünermelová
Tomáš Božovský
J Adamkova
Denisa Zimova
Show All
Source
Cite
Save
Citations (0)
Encephalitis with anti-NMDA receptor antibodies: paraneoplastic or non-paraneoplastic?
2018
Neuro endocrinology letters
Jiří Masopust
Aleš Tvaroh
Zbyšek Pavelek
Martin Vališ
Show All
Source
Cite
Save
Citations (1)
Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE:
2017
Therapeutic Advances in Neurological Disorders
Yvonne Benešová
Aleš Tvaroh
Show All
Source
Cite
Save
Citations (4)
1